International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Galipeau, J.; Krampera, M.; Barrett, J.; Dazzi, F.; Deans, R.J.; Debruijn, J.; ... ; Sensebe, L. (2016)

Article / Letter to editor

• Mesenchymal Stromal cells
• potency assays
• release assays
• matrix assays
• immune functional testing
• clinical trials
• ISCT

• All authors: Galipeau, J.; Krampera, M.; Barrett, J.; Dazzi, F.; Deans, R.J.; Debruijn, J.; Dominici, M.; Fibbe, W.E.; Gee, A.P.; Gimble, J.M.; Hematti, P.; Koh, M.B.C.; Leblanc, K.; Martin, I.; McNiece, I.K.; Mendicino, M.; Oh, S.; Ortiz, L.; Phinney, D.G.; Planat, V.; Shi, Y.F.; Stroncek, D.F.; Viswanathan, S.; Weiss, D.J.; Sensebe, L.
• Date: 2016-02-28
• Journal: Cytotherapy
• Volume: 18
• Issue: 2
• Pages: 151 - 159
• DOI: doi:10.1016/j.jcyt.2015.11.008